References
- 1. Calvo F. A. et al. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5–fluorouracil and preoperative chemoradiation, Annals of Oncology, 2006, Vol. 17, N 7, p. 1103–111010.1093/annonc/mdl085
- 2. Calvo F. A. et al. Pathologic downstaging of T3–4Nx rectal cancer after chemoradiation: 5–fluorouracil vs. Tegafur. International Journal of Radiation Oncology*Biology*Physics, 2001, Vol. 51, N 5, p. 1264–127010.1016/S0360-3016(01)01728-X
- 3. Farhat, W. et al. Factors predicting recurrence after curative resection for rectal cancer: a 16–year study. World Journal of Surgical Oncology, 2019, Vol. 17(1), N 173.10.1186/s12957-019-1718-1681954031660992
- 4. Glynne–Jones, R., Wyrwicz, L., Tiret, E., Brown, G., Rödel, C., Cervantes, A., Arnold, D., on behalf of the ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow–up. Annals of Oncology, 2017, Vol. 28, N 4, p. iv22–iv4010.1093/annonc/mdx22428881920
- 5. Khan, M. A. S. et al. Significance of R1 resection margin in colon cancer resections in the modern era. Colorectal disease, 2015, Vol. 17, N 11, p.943–95310.1111/codi.1296025808496
- 6. Mignanelli, E. D. et al. Downstaging after chemoradiotherapy for locally advanced rectal cancer: is there more (tumor) than meets the eye? Diseases of the Colon and Rectum, 2010, Vol.53, N 3, p. 251–25610.1007/DCR.0b013e3181bcd3cc20173469
- 7. NCCN Clinical Practice Guidelines in Oncology: Rectal cancer. 2019 – (atsauce 20.03.2019). Pieejams: https://www.nccn.org/professionals/physician_gls/default.aspx
- 8. Pahlman L. Radiochemotherapy as an adjuvant treatment for rectal cancer. Recent Results in Cancer Research, 1998, N 146, p.141–151.10.1007/978-3-642-71967-7_139670257
- 9. Pavlova, J. et al. Pirmsoperācijas staru terapija un ķīmijterapija – lokāli izplatīta taisnās zarnas vēža veiksmīgas ārstēšanas stūrakmens. Latvijas ārsts, 2017, Nr. 7, 33–38.lpp. 3
- 10. Quah, H. M. et al. Pathologic stage is most prognostic of disease–free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer, 2008, Vol. 113, N 1, p. 57–6410.1002/cncr.2351618442099
- 11. Rödel, C. et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. Jorunal of Clinical Oncology, 2005, Vol. 23, N 34, p. 8688–869610.1200/JCO.2005.02.132916246976
- 12. Sirohi, B. et al. Down–staging following neoadjuvant chemo–radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter? Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology, 2014, Vol. 35, N 4, p. 263–26610.4103/0971-5851.144986426427125538402
- 13. Statistikas dati par pacientu skaitu sadalījumā pa reǵioniem, lokalizācijas veidiem, dzimuma un vecuma grupām no 2001.gada līdz 2017.gadam – (atsauce 20.03.2019). Pieejams: https://www.spkc.gov.lv/lv/statistika–un–petijumi/statistika/veselibas–aprupes–statistika1
- 14. Ward, S. E., et al. The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer. British journal of cancer, 2006, Vol. 95, N 1, p.27–3410.1038/sj.bjc.6603215236049816804526